Memphasys Ltd

MEM

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    28

Stocks News & Analysis

stocks

ASX listed bank overvalued despite strong earnings

Profit beats drive shares higher for Australia’s largest asset manager.
stocks

After earnings, is Amazon a buy, a sell, or fairly valued?

After the launch of Amazon Supply Chain Services, here’s what we think of the stock.
stocks

ASX retail share expected to recover despite choppy conditions

Weakening consumer demand a temporary headwind for ASX retailer.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,942.4014.500.16%
CAC 408,056.3856.19-0.69%
DAX 4024,350.2811.650.05%
Dow JONES (US)49,611.061.900.00%
FTSE 10010,269.4336.360.36%
HKSE26,406.8413.130.05%
NASDAQ26,297.2150.130.19%
Nikkei 22562,417.88295.77-0.47%
NZX 50 Index13,210.4835.350.27%
S&P 5007,417.5218.590.25%
S&P/ASX 2008,701.8011.500.13%
SSE Composite Index4,225.0245.071.08%

Market Movers